FDA Inspection
SterRx, LLCSterRx, LLC – FDA Inspection, Jun 28, 2023
Record Details
This FDA Inspection record concerns SterRx, LLC, with an inspection on June 28, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5abddc7d-afba-44e6-8e1f-6fe41c7585b9
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1209342
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
14- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.194(a)(8)Second person sign off
- 21 CFR 211.28(a)Protective Apparel Not Worn
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.80(b)Handling and Storage to Prevent Contamination
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.194(a)(8)Second person sign off
- 21 CFR 211.28(a)Protective Apparel Not Worn
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
Showing 10 of 14 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of SterRx, LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 4, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2019 | Not classified | New York District Office | |
| March 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for SterRx, LLC
- FDA Inspection 1156750 - 2021-11-04
- FDA Inspection 1097893 - 2019-06-07
- FDA Inspection 1007560 - 2017-03-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.